Lv1
60 积分 2025-07-28 加入
Genomic and immunophenotypic landscape of early-stage pulmonary carcinoid tumors
6个月前
已完结
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
7个月前
已完结
Major pathological remissions in a patient with stage IIIA nonsmall cell lung cancer after neoadjuvant tislelizumab combined with chemotherapy: a case report and literature review
7个月前
已完结
Comparative efficacy and safety of neoadjuvant immunochemotherapy versus chemotherapy in locally advanced esophageal squamous cell carcinoma: a dual-center retrospective study
7个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
7个月前
已完结
Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention
8个月前
已完结
Glycogen drives tumour initiation and progression in lung adenocarcinoma
8个月前
已完结
Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
8个月前
已完结
Molecular mechanisms underlying the beneficial effects of Astaxanthin on metabolic changes in lung cancer and diabetes mellitus: A dual pathophysiological perspective
8个月前
已完结
The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096)
9个月前
已完结
皖公网安备34019202002308
